Trucheck Cancer Screening

The Trucheck Cancer Screening is a liquid biopsy blood test that screens for circulating tumour cells (CTCs) across 70 cancer types from a single blood draw. Unlike traditional cancer screening methods that test for individual cancers one at a time (mammography for breast, colonoscopy for colon, PSA for prostate), Trucheck uses a single blood sample to screen across a broad spectrum of cancer types simultaneously.

The test works by detecting circulating tumour cells — cells that have detached from a tumour and entered the bloodstream. The presence of CTCs can indicate cancer at an earlier stage than many conventional screening methods, potentially before symptoms develop or tumours become visible on imaging. The technology has been validated in clinical studies and is used by integrative and preventive medicine practitioners as a complement to standard screening…

At EUR 1,389, this is Drip IV Portugal's premium blood test and the most expensive panel in their catalogue. It is relevant for patients with a family history of cancer who want proactive screening beyond standard protocols, health-conscious individuals seeking the most comprehensive available cancer screening, and those who want to add a cancer screening layer to their regular health monitoring.